ArticleTurkish journal of medical sciences2026
Long-term outcomes of lamellar crescentic wedge resection on corneal astigmatism and optical aberrations in patients with advanced pellucid marginal degeneration.
Article in Turkish journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: The present study investigates the long-term changes in corneal astigmatism and aberrations following lamellar wedge resection in cases with advanced pellucid marginal degeneration (PMD). Materials and methods: Patients with advanced PMD whose visual acuity did not improve with glasses or contact lenses underwent lamellar crescentic wedge resection. Pre- and postoperative assessments at 3, 6, 12, and 24 months using Pentacam HR were conducted to identify changes in corrected visual acuity, corneal astigmatism, and higher-order aberrations (HOAs) following the procedure, and compared with a control group. Results: Statistically significant postoperative improvements in corrected visual acuity were observed at 6 and 12 months compared to preoperative values. At postoperative 3, 6, 12, and 24 months, significant improvements from preoperative values were noted in logMAR, astigmatism, and Kmax parameters (p < 0.05). A comparison of the patients with PMD and a control group revealed significant postoperative reductions in anterior and posterior coma, trefoil, spherical, and tetrafoil aberrations at 4 mm and 6 mm (p < 0.05). Most parameters remained statistically different from the healthy controls, indicating improvement without complete normalization. Although no significant difference was noted in the 6 mm anterior root mean square (RMS) value, a statistically significant reduction was observed in the 6 mm posterior RMS value at postoperative 3 and 6 months (p < 0.05). Conclusion: Lamellar crescentic wedge resection may be considered an appropriate and relatively safe surgical option for selected patients with advanced PMD, avoiding the risks associated with open-eye surgery, graft rejection, and secondary glaucoma. Long-term improvements in visual acuity, corneal astigmatism, and selected HOAs were noted following the procedure. Given the limited sample size and exploratory study design, these findings should be interpreted with caution and considered hypothesis-generating rather than definitive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.